Barclays »

Fate Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.4M 324k 7.34
2023-12-31 $1.3M 359k 3.74
2023-09-30 $253k 119k 2.13
2023-06-30 $2.3M 479k 4.76
2023-03-31 $2.9M 501k 5.70
2022-12-31 $2.7M 264k 10.09
2022-09-30 $4.0M 179k 22.42
2022-06-30 $515k 21k 24.75
2022-03-31 $830k 21k 38.79
2021-12-31 $6.2M 106k 58.51
2021-09-30 $3.2M 55k 59.25
2021-06-30 $3.7M 43k 86.79
2021-03-31 $9.1M 110k 82.44
2020-12-31 $12M 130k 90.93
2020-09-30 $6.4M 159k 39.97
2020-06-30 $4.7M 137k 34.30
2020-03-31 $2.4M 110k 22.22
2019-12-31 $1.2M 61k 19.57
2019-09-30 $858k 55k 15.55
2019-06-30 $1.6M 77k 20.31
2019-03-31 $576k 33k 17.55
2018-12-31 $416k 33k 12.82
2018-09-30 $547k 34k 16.31
2018-06-30 $85k 7.4k 11.42
2018-03-31 $184k 19k 9.80
2017-12-31 $38k 6.2k 6.10
2017-09-30 $11k 2.7k 4.10
2017-06-30 $0 12k 0.00
2017-03-31 $147k 25k 5.83